Inventor · disambiguated record
Stanley Chamberlain
Also filed as: CHAMBERLAIN STANLEY · CHAMBERLAIN STANLEY D · CHAMBERLAIN STANLEY DAWES
18 granted patents·7 pending applications·260 citations·filing 1995–2023
94Inventor score
Files withSMITHKLINE BEECHAM CORP9GLAXO WELLCOME INC4T3D THERAPEUTICS INC2BOYD F LESLIE1CHAMBERLAIN STANLEY1
Top patents by PatentIndex Score
25 records- 0190US8759318B2Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infectionsCHAMBERLAIN STANLEY·Filed 2010·Granted Jun 24, 2014·70 cites·78 claims
- 0289US7109209B2Pyrazolopyridines, process for their preparation and use as therapeutic compoundsSMITHKLINE BEECHAM CORP·Filed 2005·Granted Sep 19, 2006·8 cites·22 claims
- 0387US6919352B2Pyrazolopyridinyl pyridine and pyrimidine therapeutic compoundsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Jul 19, 2005·25 cites·19 claims
- 0484US9351989B2Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infectionsMCGUIGAN CHRIS·Filed 2011·Granted May 31, 2016·14 cites·7 claims
- 0584US6307043B1Benzimidazole and its ribonucleosideGLAXO WELLCOME INC·Filed 2000·Granted Oct 23, 2001·16 cites·2 claims
- 0681US7491731B2Crystal structure of liganded cFMS kinase domainSMITHKLINE BEECHAM CORP·Filed 2006·Granted Feb 17, 2009·3 cites·4 claims
- 0780US7087618B2Pyrazolopyridinyl pyrimidine therapeutic compoundsSMITHKLINE BEECHAM CORP·Filed 2005·Granted Aug 8, 2006·3 cites·27 claims
- 0879US6077832AAntiviral benzimidazole nucleoside analogues and a method for their preparationGLAXO WELLCOME INC·Filed 1995·Granted Jun 20, 2000·33 cites·30 claims
- 0978US7338959B2Diamino-pyrimidines and their use as angiogenesis inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Mar 4, 2008·16 cites·33 claims
- 1076US7981903B22-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancerGLAXOSMITHKLINE LLC·Filed 2008·Granted Jul 19, 2011·4 cites·17 claims
- 1173US6617315B1Therapeutic compoundsFiled 2000·Granted Sep 9, 2003·9 cites·5 claims
- 1272US7034030B2Pyralopyridines, process for their preparation and use as therapeutic compoundsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Apr 25, 2006·6 cites·25 claims
- 1370US5998605AAntiviral benzimidazole nucleoside analogues and method for their preparationGLAXO WELLCOME INC·Filed 1998·Granted Dec 7, 1999·21 cites·1 claims
- 1469US6455507B1Benzimidazole derivativesSMITHKLINE BEECHAM CORP·Filed 1998·Granted Sep 24, 2002·27 cites·29 claims
- 1563US2004002145A1Crystal structure of liganded cFMS kinase domainFiled 2003·Application pending·0 cites
- 1660US7163940B2Pyrazolopyridinyl pyrimidine therapeutic compoundsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Jan 16, 2007·1 cites·25 claims
- 1756US2025099434A1Methods of treating amyloid related brain disorders using novel compounds and antibodiesT3D THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1855US7160897B2Therapeutic compoundsSMITHKLINE BEECHAM CORP·Filed 2005·Granted Jan 9, 2007·0 cites·2 claims
- 1950US2001003744A1Therapeutic compoundsFiled 2000·Application pending·0 cites
- 2048US2007287721A1Pyrazolopyridinyl pyridineBOYD F LESLIE·Filed 2006·Application pending·0 cites
- 2143US2021369680A1Methods of treating diseases and disorders resulting from beta coronavirus infectionT3D THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2238US2014286903A1Substituted Purine Nucleosides, Phosphoramidate and Phosphordiamidate Derivatives for Treatment if Viral InfectionsINHIBITEX INC·Filed 2012·Application pending·0 cites
- 2337US2005009845A1Thienopyrimidine compounds as protein tyrosine kinase inhibitorsFiled 2002·Application pending·0 cites
- 2436US6413938B1Benzimidazole derivatives for the treatment of viral infectionsUNIV MICHIGAN·Filed 1998·Granted Jul 2, 2002·2 cites·10 claims
- 2535US6204249B1L-benzimidazole nucleosidesGLAXO WELLCOME INC·Filed 1996·Granted Mar 20, 2001·2 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Stanley Chamberlain files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →